This article discusses the minimal MOUD services available at Alaska’s Department of Corrections, as well as how MOUD access varies across the United States. Learn more →
SAMHSA’s report on importance of MOUD availability in carceral facilities. Learn more →
This study looks at who qualifies for substance use treatment while incarcerated and factors that affect their access to treatment. Learn more →
A study was conducted that surveyed U.S. jails about MOUD accessibility and challenges for increased availability. Learn more →
This article discusses the importance of MOUD in carceral facilities, progress that has been made, and where improvements are still necessary. Learn more →
The Pennsylvania Institutional Law Project (PILP) has released an updated report documenting MOUD availability in Pennsylvania’s jails. Learn more →
A study was conducted focusing on the relationship between characteristics of jails and opioid use disorder treatment availability. Learn more →
A study has found that jails do not have adequate screening for substance use disorders (especially opioid use disorder), which negatively affects access to treatment. Learn more →
A study found that at the Massachusetts Department of Corrections, when buprenorphine was offered during incarceration in addition to naltrexone, buprenorphine receipt increased and naltrexone receipt decreased after release. Learn more →
A bill has been passed by the Utah Senate and House that would allow a person who was receiving medication for opioid use in the community or at a jail to continue receiving treatment if incarcerated at a prison. Learn more →